| Current price | $6.12 | 52-week high |
|---|---|---|
| Day low | $5.47 | Volume |
| Day high | $6.30 | Avg. volume |
| 50-day MA | $0.34 | Dividend yield |
| 200-day MA | $0.37 | Market Cap |
What does bpmx stand for?
BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX" or the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced that, in anticipation of closing its merger with Timber Pharmaceuticals, it will effect a 1-for-12 reverse stock split of its outstanding common stock.
What is biopharmx's (bpmx) stock symbol?
What is Biopharmx's stock symbol? Biopharmx trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "BPMX." How do I buy shares of Biopharmx?
Where can I buy shares of bpmx?
Shares of BPMX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Which stocks are quantitatively similar to bpmx?
Stocks that are quantitatively similar to BPMX, based on their financial statements, market capitalization, and price volatility, are ZYNE, RVNC, SAGE, PRTA, and NLNK. BPMX's SEC filings can be seen here. And to visit BioPharmX Corp's official web site, go to www.biopharmx.com. Loading, please wait... Loading social stream, please wait...
How has Biopharmx's stock price performed in 2022?
Biopharmx's stock was trading at $0.3330 at the start of the year. Since then, BPMX stock has decreased by 6.9% and is now trading at $0.31. View...
How were Biopharmx's earnings last quarter?
Biopharmx Corp (NYSEAMERICAN:BPMX) released its earnings results on Tuesday, December, 10th. The biotechnology company reported ($1.68) EPS for the...
When did Biopharmx's stock split? How did Biopharmx's stock split work?
Biopharmx shares reverse split on Tuesday, May 19th 2020. The 1-12 reverse split was announced on Friday, May 15th 2020. The number of shares owned...
Who are Biopharmx's key executives?
Biopharmx's management team includes the following people: Dr. David S. Tierney M.D. , Pres, CEO, CFO and Director (Age 55) Dr. Kin Foong Chan ,...
Who are some of Biopharmx's key competitors?
Some companies that are related to Biopharmx include Liberty Biopharma (LTY) , Quest PharmaTech (QPT) , AorTech International (AOR) , OptiBioti...
What other stocks do shareholders of Biopharmx own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Biopharmx investors own include Sarepta Therapeutics (SRPT...
What is Biopharmx's stock symbol?
Biopharmx trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "BPMX."
How do I buy shares of Biopharmx?
Shares of BPMX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is Biopharmx's stock price today?
One share of BPMX stock can currently be purchased for approximately $0.31.
Component Grades
BPMX Stock Summary
We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.
Latest BPMX News From Around the Web
With a price/sales ratio of 1,474.06, BioPharmX Corp has a higher such ratio than 99.74% of stocks in our set.
Continue Researching BPMX
Below are the latest news stories about BioPharmX Corp that investors may wish to consider to help them evaluate BPMX as an investment opportunity.
Signals & Forecast
Want to see what other sources are saying about BioPharmX Corp's financials and stock price? Try the links below:
Support, Risk & Stop-loss
A buy signal was issued from a pivot bottom point on Thursday, January 27, 2022, and so far it has risen 21.43%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).
Is BioPharmX Corporation stock A Buy?
BioPharmX Corporation finds support from accumulated volume at $0.33 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
About BioPharmX Corporation
BioPharmX Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Golden Star Signal
BioPharmX Corporation, a specialty pharmaceutical company, focuses on the development of novel drug delivery products for women's health and dermatology markets. The company offers prescription and over-the-counter (OTC) products in oral, topical, and injectable forms.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
